24/7 Emergency & General Advisory
🚨 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM – 6:00 PM, Mon–Sat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
Rothmund-Thomson Syndrome (RTS) is a rare genetic disorder affecting skin, eyes, hair, and bones. Learn about its symptoms, causes, diagnosis, treatment, and outlook.
Rothmund-Thomson Syndrome (RTS) is an extremely rare genetic disorder that affects various parts of the body, including the skin, eyes, hair, and bones. It is an autosomal recessive condition, meaning that an individual must inherit two copies of a mutated gene – one from each parent – to develop the syndrome. In some instances, individuals with RTS may not exhibit changes in these specific genes, though the exact reasons for this are not yet fully understood by researchers.
RTS impacts a person's physical development and appearance. It can lead to skin issues, an increased risk of certain cancers, or both, requiring ongoing monitoring and management. Importantly, RTS does not affect a person's cognitive abilities or their capacity to learn.
The initial symptom of RTS typically appears between 3 to 6 months of age, presenting as a rash. This rash often begins with redness, swelling, or blistering on the face, particularly the cheeks. As it progresses, it can spread to other parts of the body and develop into a chronic condition known as poikiloderma. Poikiloderma is characterized by:
Other common symptoms associated with RTS include:
RTS is caused by mutations in specific genes, most commonly the RECQL4 gene or, less frequently, the ANAPC1 gene. These genetic changes occur during reproduction, with both parents passing along a mutated gene. It is crucial to understand that parents who carry a mutated gene are often asymptomatic carriers, meaning they do not display any symptoms of the syndrome themselves.
For a child to develop RTS, they must inherit one mutated gene from each parent. If both parents are carriers, there is a 25% chance with each pregnancy that their child will be born with RTS. A 50% chance exists for the child to be an asymptomatic carrier (inheriting one mutated gene), and a 25% chance for the child to inherit no mutated genes and be unaffected.
It's important to note that in some rare cases, individuals diagnosed with RTS do not have identifiable mutations in these specific genes. The reasons behind this are still a subject of ongoing research.
Diagnosing RTS typically begins with a clinical suspicion raised by a pediatrician. If a child presents with the characteristic rash, along with other combined symptoms such as skeletal abnormalities, sparse hair, or developmental delays, the pediatrician may suspect RTS.
The definitive diagnosis is usually confirmed through genetic testing. This involves a blood test to analyze the DNA for mutations in the RECQL4 and ANAPC1 genes. Identifying these specific genetic changes provides a conclusive diagnosis.
Currently, there is no cure for Rothmund-Thomson Syndrome, nor is there a standard, one-size-fits-all treatment protocol. Once diagnosed, individuals live with the condition throughout their lives. Treatment is highly individualized and focuses on managing and addressing the specific health issues and symptoms that arise.
Management strategies may include:
The primary goal of treatment is to improve the quality of life, manage symptoms effectively, and detect and treat any potential complications, such as cancer, at the earliest possible stage.
Rothmund-Thomson Syndrome is a genetic disorder, meaning it is inherited and cannot be prevented. Individuals are born with the genetic predisposition for the condition. For families with a known history of RTS or genetic carriers, genetic counseling can provide valuable information about the risks of passing on the condition and discuss options for family planning.
The outlook for individuals with Rothmund-Thomson Syndrome is generally positive, as the condition does not typically shorten life expectancy. The primary exception to this is when individuals develop cancer, which can significantly impact prognosis. However, with diligent monitoring and timely treatment of any arising health issues, including cancer, individuals with RTS can lead fulfilling and relatively typical lives.
It is important for individuals with RTS and their families to work closely with a multidisciplinary healthcare team to manage the condition effectively and ensure the best possible outcomes.
If you notice a persistent rash on your infant's face, especially if it is accompanied by redness, swelling, or blistering, it is crucial to consult a pediatrician promptly. Early detection and diagnosis are key to managing RTS and its associated symptoms effectively. Additionally, if there is a known family history of genetic disorders or RTS, seeking genetic counseling and regular medical check-ups is advisable.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Visit Hospital
Near You
Can a simple blood draw really predict dementia decades before memory problems start? In 2026, several major studies said yes — one found a protein called p-tau217 predicted risk up to 25 years ahead in women, while another found a 78% risk of cognitive impairment within 10 years in people with the
July 23, 2026
Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026